Cite
Bułdak Ł, Machnik G, Bułdak RJ, et al. Corrigendum to "Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner" [Pharmacological Reports 68 (2016) 329-337]. Pharmacol Rep. 2017;69(2):376doi: 10.1016/j.pharep.2016.12.009.
Bułdak, �. �., Machnik, G., Bułdak, R. J., Łabuzek, K., Bołdys, A., Belowski, D., Basiak, M., & Okopień, B. (2017). Corrigendum to "Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner" [Pharmacological Reports 68 (2016) 329-337]. Pharmacological reports : PR, 69(2), 376. https://doi.org/10.1016/j.pharep.2016.12.009
Bułdak, Łukasz, et al. "Corrigendum to "Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner" [Pharmacological Reports 68 (2016) 329-337]." Pharmacological reports : PR vol. 69,2 (2017): 376. doi: https://doi.org/10.1016/j.pharep.2016.12.009
Bułdak Ł, Machnik G, Bułdak RJ, Łabuzek K, Bołdys A, Belowski D, Basiak M, Okopień B. Corrigendum to "Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner" [Pharmacological Reports 68 (2016) 329-337]. Pharmacol Rep. 2017 Apr;69(2):376. doi: 10.1016/j.pharep.2016.12.009. Epub 2017 Feb 05. PMID: 28179083.
Copy
Download .nbib